neuro42
Latest round
- Series A
Last raised
- May 2024
Total raised
- $13M
Investors
- 3
About neuro42
Founded in 2020 and based in California, US, neuro42, Inc. operates as a developer of magnetic resonance imaging technology and robotics for screening, diagnosis, and treatment of neurological diseases. As of 2024, the company is headed by its CEO Amit Vohra. The flagship product of Neuro42 is a portable MRI platform that features advanced artificial intelligence and robotics. This platform facilitates screening, diagnosis, and live image-guided interventions with minimal setup and seamless integration into existing procedural workflows. The system aims to enhance both the patient and physician experience by providing high-quality imaging and operational efficiency.
Who invested in neuro42
3 investors across 2 rounds
See all investors in neuro42
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about neuro42
Who invested in neuro42?
neuro42 has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has neuro42 raised?
neuro42 has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did neuro42 last raise money?
neuro42's most recent round on record is a Series A, in May 2024.
What does neuro42 do?
Founded in 2020 and based in California, US, neuro42, Inc.
Where is neuro42 headquartered?
neuro42 is headquartered in San Francisco, US.
Which VCs invest in companies like neuro42?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at neuro42's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like neuro42? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.